openPR Logo
Press release

Radiopharmaceutical Theranostics Market: Exponential Growth, Key Stakeholders, and Emerging Trends

01-28-2025 11:00 AM CET | Health & Medicine

Press release from: The Business research company

Radiopharmaceutical Theranostics Market Share

Radiopharmaceutical Theranostics Market Share

"
Stellar Growth in Radiopharmaceutical Theranostics Market Driven by Innovations in Nuclear Medicine and Rising Incidence of Cancer

What Is The Projected Market Size Of The Global Radiopharmaceutical Theranostics Market And Its Growth Rate?
The global radiopharmaceutical theranostics market has exhibited significant growth and is expected to continue this trend.
•2024 Market Size: $2.88 billion
•2025 Market Size: $3.27 billion (13.7% CAGR)
•2029 Market Size: $5.76 billion (15.2% CAGR)
The market growth is spurred by developments in radiopharmaceuticals as well as progress in nuclear medicine and clinical research.

What Is Driving The Growth In The Radiopharmaceutical Theranostics Market?
The growth of the radiopharmaceutical theranostics market is predominantly driven by the rising incidence of cancer. Cancer, being an abnormal growth of cells that can invade and spread to other parts of the body, finds a targeted and personalized treatment approach via radiopharmaceutical theranostics. As per estimates from the American Cancer Society, around 1.9 million new cancer cases were diagnosed in the US in 2023, with about 609,820 deaths associated with the disease. Significantly, around 88% of these incidents involved individuals from the age group of 50 years and above, thus emphasizing the utility of radiopharmaceutical theranostics in cancer treatment.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11951&type=smp

Who Are the Key Players Driving Radiopharmaceutical Theranostics Market Growth?
The key players propelling the growth in the market include:
•Cardinal Health Inc.
•GE HealthCare Technologies Inc.
•Bayer AG
•China Grand Pharmaceutical & Healthcare
•Lantheus Medical Imaging Inc.
•Curium Pharma
•Advanced Accelerator Applications
•Telix Pharmaceuticals Ltd.
•Bracco Imaging S.p.A
•NTP Radioisotopes SOC Ltd.
And many more.

What Are The Key Trends In The Radiopharmaceutical Theranostics Market?
The major trends shaping the market are:
•Ethical and legal considerations
•Telemedicine in theranostics
•Patient-centric care
•Radiopharmaceutical customization
•Nano-theranostics development

What Are The Segments Of The Global Radiopharmaceutical Theranostics Market?
The market segments include:
1) Product Type: Alpha Emitters, Beta Emitters, Positron Emission Tomography (PET) Tracers
2) Source: Nuclear Reactors, Cyclotrons
3) Radioisotope: Technetium-99, Gallium-68, Iodine-131, Iodine-123, 18F, Y-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and other radioscopes.
4) Indication: Oncology, Cardiology, Neurology, Other Indications
5) End User: Hospitals, Diagnostic Imaging Centers, Academic And Research Institutes, Other End Users

Which Region Leads The Radiopharmaceutical Theranostics Market?
North America emerged as the largest region in the radiopharmaceutical theranostics market in 2024. The market report covers other regions such as Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa.

Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/radiopharmaceutical-theranostics-global-market-report

What Is Covered In The Radiopharmaceutical Theranostics Market Global Market Report?
- Market Size Analysis: Analyze the Radiopharmaceutical Theranostics Market size by key regions, countries, product types, and applications.

- Market Segmentation Analysis: Identify various subsegments within the Radiopharmaceutical Theranostics Market for effective categorization.

- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.

- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.

- Market Contribution: Evaluate contributions of different segments to the overall Radiopharmaceutical Theranostics Market growth.

- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.

- Industry Challenges: Analyze challenges and risks affecting the Radiopharmaceutical Theranostics Market.

- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=11951&type=smp

Learn More About The Business Research Company
The Business Research Company offers over 15,000+ reports across 27 industries and covers 60+ geographies. Our Global Market Model, a premier market intelligence platform, delivers comprehensive and updated forecasts to aid strategic decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiopharmaceutical Theranostics Market: Exponential Growth, Key Stakeholders, and Emerging Trends here

News-ID: 3836851 • Views:

More Releases from The Business research company

2025-2034 Laboratory Information System Market Evolution: Disruptions, Innovations, and Untapped Opportunities
2025-2034 Laboratory Information System Market Evolution: Disruptions, Innovatio …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Laboratory Information System Market Through 2025? The size of the laboratory information system market has experienced robust expansion lately, projected to ascend from its 2024 valuation of $2.57 billion to $2.73 billion by 2025, reflecting a compound annual growth rate (CAGR) of
Global Hiv Cases Drive Demand For Flow Cytometry In Diagnosis: Critical Driver Shaping the Global Flow Cytometry Market in 2025
Global Hiv Cases Drive Demand For Flow Cytometry In Diagnosis: Critical Driver S …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Flow Cytometry Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The expanse of the flow cytometry market has shown remarkable upward momentum across recent years, projected to increase its valuation from a figure of $6.88 billion in 2024 to $7.49 billion come 2025, reflecting an
Emerging Trends to Drive Secure Messaging In Healthcare Market Growth at 19% CAGR Through 2029
Emerging Trends to Drive Secure Messaging In Healthcare Market Growth at 19% CAG …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Secure Messaging In Healare Market Size Growth Forecast: What to Expect by 2025? The sphere of secure messaging within the healare sector has experienced substantial recent expansion, projected to advance from a valuation of $0.83 billion in the year 2024 to $0.99 billion by 2025, reflecting an annualized growth
Rising Security Breaches Drive Growth In Healthcare Identity Management Market: Strategic Insights Driving Healthcare Identity Management Market Momentum in 2025
Rising Security Breaches Drive Growth In Healthcare Identity Management Market: …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Healare Identity Management Market Size By 2025? Recent years have marked a swift expansion in the scale of the healare identity management sector, projected to increase from a value of $4.57 billion in 2024 to $5.14 billion throughout 2025, reflecting an annual compound growth rate

All 5 Releases


More Releases for Radiopharmaceutical

Radiopharmaceutical Preclinical CRO Market Dynamics Shaped by Increasing Focus o …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radiopharmaceutical Preclinical CRO Market Size, Share & Trends Analysis Report By Organization Size (Small and Medium Enterprises (SMEs), Large Pharmaceutical Corporations), Radiopharmaceutical Types (PET Tracers, SPECT Tracers, Therapeutic Radiopharmaceuticals), Services (Safety Assessment, Bioanalytical Testing, Dose Formulation, Regulatory Affairs Support) Therapeutic Area (Oncology, Cardiology, Neurology), End-Users (Pharmaceutical Companies, Biotechnology Firms, Academic Research Institutions, Government Organizations)- Market
Radiopharmaceutical/Nuclear Medicine Market Size and Trends
The radiopharmaceutical/nuclear medicine market is poised for significant expansion in the coming years. With advancements in technology, increasing disease prevalence, and a growing emphasis on personalized medicine, the market presents lucrative opportunities for stakeholders. As the healthcare landscape evolves, the integration of innovative radiopharmaceuticals into clinical practice will continue to enhance diagnostic and therapeutic outcomes, ultimately improving patient care. The key players in the radiopharmaceutical/nuclear medicine market include Eckert & Ziegler,
Radiopharmaceutical Market 2021 | Detailed Report
Radiopharmaceutical Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Radiopharmaceutical Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4123322 The report provides a comprehensive analysis of company profiles listed below: - Bracco Imaging - Bayer - Mallinckrodt - Nordion - Triad Isotopes - Lantheus -
Impressive Trends and Future Scope of Radiopharmaceutical Market
Radiopharmaceutical Market: Introduction According to the report, the global radiopharmaceutical market was valued at US$ 3.6 Bn in 2018 and is projected to expand at a CAGR of ~4% from 2019 to 2027. Some of the factors driving the radiopharmaceutical market are expansion activities of key radiopharma players; applications in clinical trials; and increase in aging population, pipeline assessment of new drugs, and disease indication mortality. Shutdown of some of the
Radiopharmaceutical Market Development Status and Outlook 2024
Radiopharmaceutical Market: Snapshot The global market for radiopharmaceuticals is poised for steady growth in the coming years, driven primarily by the rising use of radioisotopes for the treatment of various diseases, such as cancer, bone palliation, neurological disorders, and cardiovascular diseases. Around 35 million patients undergo treatment procedures for these diseases each year and this will continue to boost the demand for radiopharmaceuticals. Read Report Overview for Radiopharmaceutical Market: http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html According to the
Competition Landscape for Radiopharmaceutical Market Global Industry 2024
The global radiopharmaceutical market was valued at US$4.7 bn in 2015 and is estimated to reach US$7.4 bn by 2024, expanding at a CAGR of 5.3% from 2016 to 2024. Download Exclusive Global Strategic Business Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=213 Radiopharmaceutical Market: Snapshot The global market for radiopharmaceuticals is poised for steady growth in the coming years, driven primarily by the rising use of radioisotopes for the treatment of various diseases, such as cancer, bone palliation, neurological